Combined effects of coffee consumption and serum γ- glutamyltransferase on serum C-reactive protein in middle-aged and elderly Japanese men and women

Clinical Chemistry and Laboratory Medicine

Volumn 49, Issue 10, 2011, Pages 1661-1667

  Pham, Ngoc Minh ^a   Zhenjie, Wang ^a   Morita, Makiko ^a   Ohnaka, Keizo ^a   Adachi, Masahiro ^a   Kawate, Hisaya ^a   Takayanagi, Ryoichi ^a   Kono, Suminori ^a  

^a KYUSHU UNIVERSITY   (Japan)

Author keywords

glutamyltransferase; bilirubin; C reactive protein; coffee; effect modification

Indexed keywords

BILIRUBIN; C REACTIVE PROTEIN; GAMMA GLUTAMYLTRANSFERASE;

ADULT; AGED; ALCOHOL CONSUMPTION; ANTIOXIDANT ACTIVITY; ARTICLE; BILIRUBIN BLOOD LEVEL; BODY HEIGHT; BODY MASS; BODY WEIGHT; COFFEE; COHORT ANALYSIS; DIABETES MELLITUS; DIASTOLIC BLOOD PRESSURE; DIETARY INTAKE; FEMALE; FOOD INTAKE; GAMMA GLUTAMYL TRANSFERASE BLOOD LEVEL; HUMAN; HYPERCHOLESTEROLEMIA; HYPERTENSION; JAPAN; JAPANESE; LIFESTYLE; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; OXIDATIVE STRESS; PHYSICAL ACTIVITY; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; SEX DIFFERENCE; SMOKING; SYSTOLIC BLOOD PRESSURE; TEA;

AGED; BILIRUBIN; C-REACTIVE PROTEIN; COFFEE; DOWN-REGULATION; FEMALE; GAMMA-GLUTAMYLTRANSFERASE; HUMANS; INFLAMMATION; JAPAN; MALE; MIDDLE AGED; REGRESSION ANALYSIS;

EID: 80054878554     PISSN: 14346621     EISSN: 14374331     Source Type: Journal    
DOI: 10.1515/CCLM.2011.652     Document Type: Article

References (41)

1. Pepys MB, Hirschfield GM. C-reactive protein: A critical update. J Clin Invest 2003;111:1805-12. (Pubitemid 38057722)
2. Nanri A, Moore MA, Kono S. Impact of C-reactive protein on disease risk and its relation to dietary factors. Asian Pac J Cancer Prev 2007;8:167-77.
3. Brooks GC, Blaha MJ, Blumenthal RS. Relation of C-reactive protein to abdominal adiposity. Am J Cardiol 2010;106:56-61.
4. Bazzano LA, He J, Muntner P, Vupputuri S, Whelton PK. Relationship between cigarette smoking and novel risk factors for cardiovascular disease in the United States. Ann Intern Med 2003;138:891-7.
5. Bakhru A, Erlinger TP. Smoking cessation and cardiovascular disease risk factors: Results from the Third National Health and Nutrition Examination Survey. PLoS Med 2005;2:e160.
6. Pai JK, Hankinson SE, Thadhani R, Rifai N, Pischon T, Rimm EB. Moderate alcohol consumption and lower levels of inflammatory markers in US men and women. Atherosclerosis 2006; 186:113-20.
7. Esmaillzadeh A, Kimiagar M, Mehrabi Y, Azadbakht L, Hu FB, Willett WC. Fruit and vegetable intakes, C-reactive protein, and the metabolic syndrome. Am J Clin Nutr 2006;84:1489-97. (Pubitemid 44912835)
8. Higdon JV, Frei B. Coffee and health: A review of recent human research. Crit Rev Food Sci Nutr 2006;46:101-23.
9. Schulze MB, Hoffmann K, Manson JE, Willett WC, Meigs JB, Weikert C, et al. Dietary pattern, inflammation, and incidence of type 2 diabetes in women. Am J Clin Nutr 2005;82:675-84.
10. Lopez-Garcia E, van Dam RM, Qi L, Hu FB. Coffee consumption and markers of inflammation and endothelial dysfunction in healthy and diabetic women. Am J Clin Nutr 2006; 84:888-93. (Pubitemid 44715672)
11. Williams CJ, Fargnoli JL, Hwang JJ, van Dam RM, Blackburn GL, Hu FB, et al. Coffee consumption is associated with higher plasma adiponectin concentrations in women with or without type 2 diabetes: A prospective cohort study. Diabetes Care 2008; 31:504-7.
12. Arsenault BJ, Earnest CP, Després JP, Blair SN, Church TS. Obesity, coffee consumption and CRP levels in postmenopausal overweight/obese women: Importance of hormone replacement therapy use. Eur J Clin Nutr 2009;63:1419-24.
13. Maki T, Pham NM, Yoshida D, Yin G, Ohnaka K, Takayanagi R, et al. The relationship between coffee and green tea consumption and high-sensitivity C-reactive protein in Japanese men and women. Clin Chem Lab Med 2010;48:849-54.
14. Kotani K, Tsuzaki K, Sano Y, Maekawa M, Fujiwara S, Hamada T, et al. The relationship between usual coffee consumption and serum C-reactive protein level in a Japanese female population. Clin Chem Lab Med 2008;46:1434-7.
15. Zampelas A, Panagiotakos DB, Pitsavos C, Chrysohoou C, Stefanadis C. Associations between coffee consumption and inflammatory markers in healthy persons: The ATTICA study. Am J Clin Nutr 2004;80:862-7. (Pubitemid 41202083)
16. Kempf K, Herder C, Erlund I, Kolb H, Martin S, Carstensen M, et al. Effects of coffee consumption on subclinical inflammation and other risk factors for type 2 diabetes: A clinical trial. Am J Clin Nutr 2010;91:950-7.
17. Bidel S, Silventoinen K, Hu G, Lee DH, Kaprio J, Tuomilehto J. Coffee consumption, serum gamma-glutamyltransferase and risk of type II diabetes. Eur J Clin Nutr 2008;62:178-85. (Pubitemid 351234251)
18. Whitfield JB. Gamma glutamyl transferase. Crit Rev Clin Lab Sci 2001;38:263-355. (Pubitemid 32826505)
19. Lim JS, Yang JH, Chun BY, Kam S, Jacobs DR Jr, Lee DH. Is serum gamma-glutamyltransferase inversely associated with serum antioxidants as a marker of oxidative stress? Free Radic Biol Med 2004;37:1018-23. (Pubitemid 39172131)
20. Lee DH, Jacobs DR Jr. Serum gamma-glutamyltransferase: New insights about an old enzyme. J Epidemiol Commun Health 2009;63:884-6.
21. Lee YJ, Kim JK, Lee JH, Lee HR, Kang DR, Shim JY. Association of serum gamma-glutamyltransferase with C-reactive protein levels and white blood cell count in Korean adults. Clin Chem Lab Med 2008;46:1410-5.
22. Lee DH, Jacobs DR Jr. Association between serum gammaglutamyltransferase and C-reactive protein. Atherosclerosis 2005;178:327-30. (Pubitemid 40193447)
23. McCarty MF. "Iatrogenic Gilbert syndrome"-a strategy for reducing vascular and cancer risk by increasing plasma unconjugated bilirubin. Med Hypotheses 2007;69:974-94. (Pubitemid 47430241)
24. Abraham NG, Kappas A. Pharmacological and clinical aspects of heme oxygenase. Pharmacol Rev 2008;60:79-127. (Pubitemid 351439218)
25. Schwertner HA, Vítek L. Gilbert syndrome, UGT1A.1. 28 allele, and cardiovascular disease risk: Possible protective effects and therapeutic applications of bilirubin. Atherosclerosis 2008;198: 1-11.
26. Ohnaka K, Kono S, Inoguchi T, Yin G, Morita M, Adachi M, et al. Inverse associations of serum bilirubin with high sensitivity C-reactive protein, glycated hemoglobin, and prevalence of type 2 diabetes in middle-aged and elderly Japanese men and women. Diabetes Res Clin Pract 2010;88:103-10.
27. National Kidney Foundation. K/DOQI Clinical practice guidelines for chronic kidney disease: Evaluation, classification and stratification. Am J Kidney Dis 2002;39:S1-266.
28. Matsuo S, Imai E, Horio M, Yasuda Y, Tomita K, Nitta K, et al. Revised equations for estimated GFR from serum creatinine in Japan. Am J Kidney Dis 2009;53:982-92.
29. Macy EM, Hayes TE, Tracy RP. Variability in the measurement of C-reactive protein in healthy subjects: Implications for reference intervals and epidemiological applications. Clin Chem 1997;43:52-8. (Pubitemid 27024390)
30. Dhingra R, Gona P, Nam BH, D'Agostino RB Sr, Wilson PW, Benjamin EJ, et al. C-reactive protein, inflammatory conditions, and cardiovascular disease risk. Am J Med 2007;120:1054-62. (Pubitemid 350166233)
31. Roberts WL, Sedrick R, Moulton L, Spencer A, Rifai N. Evaluation of four automated high-sensitivity C-reactive protein methods: Implications for clinical and epidemiological applications. Clin Chem 2000;46:461-8. (Pubitemid 30210716)
32. Tokuda K, Tanimoto K. A new method of measuring bilirubin in serum by vanadic acid. Jpn J Clin Chem (in Japanese with English abstract) 1993;22:116-22. (Pubitemid 23253269)
33. Tokudome Y, Goto C, Imaeda N, Hasegawa T, Kato R, Hirose K, et al. Relative validity of a short food frequency questionnaire for assessing nutrient intake versus three-day weighed diet records in middle-aged Japanese. J Epidemiol 2005;15:135-45. (Pubitemid 41403851)
34. Lee KY, Uchida K, Shirota T, Kono S. Validity of a self-administered food frequency questionnaire against 7-day dietary records in four seasons. J Nutr Sci Vitaminol (Tokyo) 2002;48: 467-76. (Pubitemid 36417620)
35. Ainsworth BE, Haskell WL, Whitt MC, Irwin ML, Swartz AM, Strath SJ, et al. Compendium of physical activities: An update of activity codes and MET intensities. Med Sci Sports Exerc 2000;32:S498-516.
36. Shimano H, Arai H, Harada-Shiba M, Ueshima H, Ohta T, Yamashita S, et al. Proposed guidelines for hypertriglyceridemia in Japan with non-HDL cholesterol as the second target. J Atheroscler Thromb 2008;15:116-21.
37. Angulo P. Nonalcoholic fatty liver disease. N Engl J Med 2002; 346:1221-31.
38. Neuschwander-Tetri BA, Caldwell SH. Nonalcoholic steatohepatitis: Summary of an AASLD Single Topic Conference. Hepatology 2003;37:1202-19. (Pubitemid 36538699)
39. Yamada S, Gotoh T, Nakashima Y, Kayaba K, Ishikawa S, Nago N, et al. Distribution of serum C-reactive protein and its association with atherosclerotic risk factors in a Japanese population: Jichi Medical School Cohort Study. Am J Epidemiol 2001;153:1183-90. (Pubitemid 32552276)
40. Novotný L, Vítek L. Inverse relationship between serum bilirubin and atherosclerosis in men: A meta-analysis of published studies. Exp Biol Med 2003;228:568-71. (Pubitemid 37203679)
41. Kinoshita S, Toyofuku M, Iida H, Wakiyama M, Kurihara M, Nakahara M, et al. Standardization of laboratory data and establishment of reference intervals in the Fukuoka Prefecture: A Japanese perspective. Clin Chem Lab Med 2001;39:256-62.